Journal of the International Academy for Case Studies (Print ISSN: 1078-4950; Online ISSN: 1532-5822)


Medisave Pharmaceutical in Regime : Issues and Prospects

Author(s): Rimsha Shahzadi, Attiqa Khaliq

This case study is based on the success story of Medisave pharmaceutical company which is well-known with the capacity of twenty-five thousand products in different categories of disease with annual sales return of 100 million rupees per month. There are 92 factories in production (as of April 2010) and an additional 102 are expected to join production by December 2010. Corruption and preferential treatment in government sectors have always laid down business in Pakistan, particularly in the pharmaceutical sector. Alike to all businesses when Medisave started, it suffered a lot of obstacles from authoritative offices. When it started incorporation costs were very serious and other requirements were high like there must be all setups above except even those as well which have no direct link with production. Medisave always believes in good corporate governance and control which fosters higher growth and development or the way round. Medisave always deem impersonal management and proper recruitment process and method which ensure the right people at the right place.

Get the App